drugset
drugset / Trial / NCT02767362

A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

NCT02767362 ↗

Phase 0 Completed 24 enrolled UNC Lineberger Comprehensive Cancer Center Wilma Williams Education and Clinical Research for Endometrial Cancer Award · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a preoperative window, phase 0 study of short-term atorvastatin treatment in obese women who are to undergo surgical staging for endometrial cancer.

Timeline

Start
2015-11
Primary completion
2019-09-26
Completion
2019-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg Oral

Indications

endometrial cancer